69 business development jobs found in Torrance, CA

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

At Tarsus, we understand the importance of attracting and retaining top talent. Tarsus Pharmaceuticals, Inc. is an Equal Opportunity Employer.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence in Dermatology, Opthalmics, Oncology, and Long Term Care.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence in Dermatology, Opthalmics, Oncology, and Long Term Care.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence in Dermatology, Opthalmics, Oncology, and Long Term Care.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence in Dermatology, Opthalmics, Oncology, and Long Term Care.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence in Dermatology, Opthalmics, Oncology, and Long Term Care.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence in Dermatology, Opthalmics, Oncology, and Long Term Care.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Come join the true partner of global healthcare companies, Amplity Health. We continually challenge the boundaries of medical and commercial strategies to accelerate the approval and launch of new drugs to improve the lives of patients.   Remote Engagement/Hybrid Pharmaceutical Sales Representative   Amplity Health has immediate opportunities.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.